Pharmacokinetic, Metabolic, and Pharmacodynamic Profiles in a Dose-Escalating Study of Irinotecan and Cisplatin
DE JONGE, M. J. A, VERWEIJ, J, DE BRUIJN, P, BROUWER, E, MATHIJSSEN, R. H. J, VAN ALPHEN, R. J, DE BOER-DENNERT, M. M, VERNILLET, L, JACQUES, C, SPORREBOOM, A
Published in Journal of clinical oncology (01.01.2000)
Published in Journal of clinical oncology (01.01.2000)
Get full text
Journal Article
A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumors
PLANTING, A. S. T, SONNEVELD, P, PAUL, E. M, PURVIS, N. B, VERWEIJ, J, VAN DER GAAST, A, SPARREBOOM, A, VAN DER BURG, M. E. L, LUYTEN, G. P. M, DE LEEUW, K, DE BOER-DENNERT, M, WISSEL, P. S, JEWELL, R. C
Published in Cancer chemotherapy and pharmacology (2005)
Published in Cancer chemotherapy and pharmacology (2005)
Get full text
Journal Article
Phase I Study of 3-Week Schedule of Irinotecan Combined With Cisplatin in Patients With Advanced Solid Tumors
DE JONGE, M. J. A, SPARREBOOM, A, PLANTING, A. S. T, VAN DER BURG, M. E. L, DE BOER-DENNERT, M. M, TER STEEG, J, JACQUES, C, VERWEIJ, J
Published in Journal of clinical oncology (01.01.2000)
Published in Journal of clinical oncology (01.01.2000)
Get full text
Journal Article
Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists
DE BOER-DENNERT, M, DE WIT, R, SCHMITZ, P. I. M, DJONTONO, J, BEURDEN, V. V, STOTER, G, VERWEIJ, J
Published in British journal of cancer (01.10.1997)
Published in British journal of cancer (01.10.1997)
Get full text
Journal Article
Drug-Administration Sequence Does Not Change Pharmacodynamics and Kinetics of Irinotecan and Cisplatin
DE JONGE, M. J. A, VERWEIJ, J, PLANTING, A. S. T, VAN DER BURG, M. E. L, STOTER, G, DE BOER-DENNERT, M. M, DE BRUIJN, P, BROUWER, E, VERNILLET, L, SPARREBOOM, A
Published in Clinical cancer research (01.08.1999)
Get full text
Published in Clinical cancer research (01.08.1999)
Journal Article
Adaptive intrapatient dose escalation of cisplatin in combination with low-dose vp16 in patients with nonsmall cell lung cancer
Schellens, J H M, Planting, A S T, van Zandwijk, N, Ma, J, Maliepaard, M, van der Burg, M E L, de Boer-Dennert, M, Brouwer, E, van der Gaast, A, van den Bent, M J, Verweij, J
Published in British journal of cancer (24.03.2003)
Published in British journal of cancer (24.03.2003)
Get full text
Journal Article
Bioavailability and pharmacokinetics of oral topotecan: a new topoisomerase I inhibitor
SCHELLENS, J. H. M, CREEMERS, G. J, BEIJNEN, J. H, ROSING, H, DE BOER-DENNERT, M, MCDONALD, M, DAVIES, B, VERWEIJ, J
Published in British journal of cancer (01.05.1996)
Published in British journal of cancer (01.05.1996)
Get full text
Journal Article
Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumors
Pronk, L C, Schellens, J H, Planting, A S, van den Bent, M J, Hilkens, P H, van der Burg, M E, de Boer-Dennert, M, Ma, J, Blanc, C, Harteveld, M, Bruno, R, Stoter, G, Verweij, J
Published in Journal of clinical oncology (01.03.1997)
Published in Journal of clinical oncology (01.03.1997)
Get more information
Journal Article
Phase II and pharmacologic study of topotecan administered as a 21-day continuous infusion to patients with colorectal cancer
Creemers, G J, Gerrits, C J, Schellens, J H, Planting, A S, van der Burg, M E, van Beurden, V M, de Boer-Dennert, M, Harteveld, M, Loos, W, Hudson, I, Stoter, G, Verweij, J
Published in Journal of clinical oncology (01.09.1996)
Published in Journal of clinical oncology (01.09.1996)
Get more information
Journal Article
Weekly high-dose cisplatin in malignant pleural mesothelioma
Planting, A. S. T., Schellens, J. H. M., Goey, S. H., van der Burg, M. E. L., de Boer-Dennert, M., Stoter, G., Verweij, J.
Published in Annals of oncology (01.04.1994)
Published in Annals of oncology (01.04.1994)
Get full text
Journal Article
Analysis of cumulative probabilities shows that the efficacy of 5HT3 antagonist prophylaxis is not maintained
de Wit, R, Schmitz, P I, Verweij, J, de Boer-Dennert, M, de Mulder, P H, Planting, A S, van der Burg, M E, Stoter, G
Published in Journal of clinical oncology (01.02.1996)
Published in Journal of clinical oncology (01.02.1996)
Get more information
Journal Article
Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours
SCHELLENS, J. H. M, MA, J, PLANTING, A. S. T, VAN DER BURG, M. E. L, VAN MEERTEN, E, DE BOER-DENNERT, M, SCHMITZ, P. I. M, STOTER, G, VERWEIJ, J
Published in British journal of cancer (01.06.1996)
Published in British journal of cancer (01.06.1996)
Get full text
Journal Article
Phase I and pharmacologic study of the arotinoid Ro 40-8757 in combination with cisplatin and etoposide in patients with non-small cell lung cancer
van Zuylen, L, Schellens, J H, Goey, S H, Pronk, L C, de Boer-Dennert, M M, Loos, W J, Ma, J, Stoter, G, Verweij, J
Published in Anti-cancer drugs (01.04.1999)
Published in Anti-cancer drugs (01.04.1999)
Get more information
Journal Article
Adaptive intrapatient dose escalation of cisplatin in patients with advanced head and neck cancer
Schellens, J H, Planting, A S, Ma, J, Maliepaard, M, de Vos, A, de Boer Dennert, M, Verweij, J
Published in Anti-cancer drugs (01.09.2001)
Published in Anti-cancer drugs (01.09.2001)
Get more information
Journal Article
Phase I and pharmacokinetics study of topotecan, a new topoisomerase I inhibitor
Verweij, J., Lund, B., Beijnen, J., de Boer-Dennert, M., Koier, I., Rosing, H., Hansen, H.
Published in Annals of oncology (01.09.1993)
Published in Annals of oncology (01.09.1993)
Get full text
Journal Article
Phase I and pharmacological study of the new topoisomerase I inhibitor GI147211, using a daily x 5 intravenous administration
Gerrits, C J, Creemers, G J, Schellens, J H, Wissel, P, Planting, A S, Kunka, R, Selinger, K, de Boer-Dennert, M, Marijnen, Y, Harteveld, M, Verweij, J
Published in British journal of cancer (01.03.1996)
Published in British journal of cancer (01.03.1996)
Get full text
Journal Article
Current sample handling methods for measurement of platinum-DNA adducts in leucocytes in man lead to discrepant results in DNA adduct levels and DNA repair
MA, J, VERWEIJ, J, PLANTING, A. S. T, DE BOER-DENNERT, M, VAN INGEN, H. E, VAN DER BURG, M. E. L, STOTER, G, SCHELLENS, J. H. M
Published in British journal of cancer (01.03.1995)
Published in British journal of cancer (01.03.1995)
Get full text
Journal Article
Pharmacokinetic profile and clinical efficacy of a once-daily ondansetron suppository in cyclophosphamide-induced emesis: a double blind comparative study with ondansetron tablets
DE WIT, R, BEIJNEN, J. H, VAN TELLINGEN, O, SCHELLENS, J. H. M, DE BOER-DENNERT, M, VERWEIJ, J
Published in British journal of cancer (01.07.1996)
Published in British journal of cancer (01.07.1996)
Get full text
Journal Article
Phase I and pharmacologic study of BMS-181174 given as a 6 h infusion every 4 weeks to patients with advanced solid tumors
Planting, A S, Schellens, J H, van der Burg, M E, de Boer-Dennert, M, Winograd, B, Stoter, G, Verweij, J
Published in Anti-cancer drugs (01.10.1999)
Published in Anti-cancer drugs (01.10.1999)
Get more information
Journal Article
The venotonic drug hydroxyethylrutosiden does not prevent or reduce docetaxel-induced fluid retention: results of a comparative study
PRONK, L. C, VAN PUTTEN, W. L. J, VAN BEURDEN, V, DE BOER-DENNERT, M, STOTER, G, VERWEIJ, J
Published in Cancer chemotherapy and pharmacology (1999)
Published in Cancer chemotherapy and pharmacology (1999)
Get full text
Journal Article